University of Utah Health Sciences
Welcome,         Profile    Billing    Logout  
 1 Trial 
8 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Havenon, Adam de
NCT05365880: Sphenopalatine Ganglion Block for the Treatment of Post-Stroke Headache

Withdrawn
2
20
US
Liquid Lidocaine, Placebo
University of Utah
Headache, Stroke, Ischemic Stroke
03/25
06/25
NCT03084523: Treatment Targets for Inflamed Intracranial Atherosclerosis on Vessel Wall MRI

Active, not recruiting
1
80
US
Ferumoxytol Injectable Product, Feraheme
Yale University
Stroke, Intracranial Atherosclerosis
12/24
12/24
RESCUE-ICAS, NCT05403593: Registry of Emergent Large VeSsel OCclUsion DuE to IntraCranial AtherosclerosiS

Completed
N/A
600
Europe, US, RoW
No Intervention
Medical University of South Carolina, University of Göttingen, Thomas Jefferson University, University of Miami, University of Basel, University of Tennessee, Wake Forest University Health Sciences, Emory University, The University of Texas Health Science Center at San Antonio, University of Iowa, Indiana University, University of Chicago, Careggi Hospital, Massachusetts General Hospital, Imam Abdulrahman Bin Faisal University, Brown University, Yale University, Sutter Health, Centro Hospitalar de Lisboa Central, HCA Houston Healthcare Kingwood, advocate christ medical center
Intracranial Stenosis, Large Vessel Occlusion, Mechanical Thrombectomy
03/24
06/24
MR SCREEN, NCT06533631: Measuring Brain Health Using Low-Field Portable MRI

Not yet recruiting
N/A
100
US
Portable low-field MRI (pMRI), 3T MRI
Yale University, National Institute of Neurological Disorders and Stroke (NINDS)
White Matter Hyperintensity
11/26
11/26
BP-VISO, NCT05756257: Blood Pressure Variability and Ischemic Stroke Outcome

Recruiting
N/A
150
US
Yale University, University of Chicago, Massachusetts General Hospital, National Institute of Neurological Disorders and Stroke (NINDS)
Acute Ischemic Stroke, Blood Pressure Variability
03/26
03/26
Larsen, Cassie
MINT, NCT05799755: Myositis Interstitial Lung Disease Nintedanib Trial

Active, not recruiting
4
70
US
Nintedanib, OFEV, Placebo, Standard of Care
Rohit Aggarwal, MD, Boehringer Ingelheim
Myositis Associated Interstitial Lund Disease (MA-ILD)
07/25
12/25
TETON, NCT04708782: Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis

Hourglass May 2024 - Aug 2024 : Topline data for IPF
Hourglass Jan 2023 - Mar 2023 : Enrollment completion of TETON trial for IPF
Recruiting
3
576
Canada, US
Placebo, Inhaled Treprostinil, Tyvaso, Treprostinil Ultrasonic Nebulizer
United Therapeutics
Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease
06/25
06/25
Suciu, Tyler
STRIVE-IPF, NCT03286556: Autoantibody Reduction for Acute Exacerbations of Idiopathic Pulmonary Fibrosis

Completed
2
51
US
Autoantibody Reductive Therapy, Treatment as Usual (TAU), Antibiotics and steroids
University of Alabama at Birmingham, National Heart, Lung, and Blood Institute (NHLBI), Brigham and Women's Hospital, Temple University, University of Pittsburgh
Idiopathic Pulmonary Fibrosis, Acute Fatal Form
08/24
08/24
Ahlstrom, Jennifer
No trials found
Smith, Andreia
No trials found

Download Options